FDA Expands Symdeko Indications
June 21, 2019
Approved to treat pediatric patients ages 6 years and older with cystic fibrosis
News
Trials for Early Onset JIA Treatment Show Promise
March 4, 2019
Historically, treatments for children with systemic juvenile idiopathic arthritis (sJIA) have been difficult and ineffective, leading to poor outcomes. But, findings from a new study point to a method that could lead to more positive results.
